HIGHLIGHTS
- What: In this review, the authors provide an updated overview of the clinical, radiological and biochemical characteristics of MOG-antibody associated disease, discuss the prognosis, 2 of 17 highlight the differences from MS and AQP4-NMOSD, and explore the acute and preventive therapeutic options.
- Who: Panagiotis Gklinos and Ruth Dobson from the First Neurology Department, Eginition University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece have published the research work: Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management, in the Journal: Antibodies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.